Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Verona Pharma PLC ADR stock

Learn how to easily invest in Verona Pharma PLC ADR stock.

Verona Pharma PLC ADR is a biotechnology business based in the US. Verona Pharma PLC ADR shares (VRNA) are listed on the NASDAQ and all prices are listed in US Dollars. Verona Pharma PLC ADR employs 24 staff and has a trailing 12-month revenue of around $40 million.

How to buy shares in Verona Pharma PLC ADR

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – VRNA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Verona Pharma PLC ADR stock price (NASDAQ: VRNA)

Use our graph to track the performance of VRNA stocks over time.

Verona Pharma PLC ADR shares at a glance

Information last updated 2022-09-25.
Latest market close$8.63
52-week range$3.41 - $14.69
50-day moving average $9.05
200-day moving average $6.07
Wall St. target price$24.71
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.99

Buy Verona Pharma PLC ADR shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$100
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Verona Pharma PLC ADR stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Verona Pharma PLC ADR price performance over time

Historical closes compared with the close of $8.63 from 2022-09-23

1 week (2022-09-19) -12.30%
1 month (2022-08-26) -18.20%
3 months (2022-06-24) 92.63%
6 months (2022-03-25) 62.52%
1 year (2021-09-24) 59.81%
2 years (2020-09-25) 34.21%
3 years (2019-09-26) 90.93%
5 years (2017-09-26) 15.04

Verona Pharma PLC ADR financials

Revenue TTM $40 million
Gross profit TTM $40 million
Return on assets TTM -17.09%
Return on equity TTM -41.33%
Profit margin -137.04%
Book value $1.83
Market capitalisation $526 million

TTM: trailing 12 months

Verona Pharma PLC ADR share dividends

We're not expecting Verona Pharma PLC ADR to pay a dividend over the next 12 months.

Verona Pharma PLC ADR share price volatility

Over the last 12 months, Verona Pharma PLC ADR's shares have ranged in value from as little as $3.408 up to $14.69. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Verona Pharma PLC ADR's is 0.4598. This would suggest that Verona Pharma PLC ADR's shares are less volatile than average (for this exchange).

Verona Pharma PLC ADR overview

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom. .

Frequently asked questions

What percentage of Verona Pharma PLC ADR is owned by insiders or institutions?
Currently 10.586% of Verona Pharma PLC ADR shares are held by insiders and 48.316% by institutions.
How many people work for Verona Pharma PLC ADR?
Latest data suggests 24 work at Verona Pharma PLC ADR.
When does the fiscal year end for Verona Pharma PLC ADR?
Verona Pharma PLC ADR's fiscal year ends in December.
Where is Verona Pharma PLC ADR based?
Verona Pharma PLC ADR's address is: 3 More London Riverside, London, United Kingdom, SE1 2RE
What is Verona Pharma PLC ADR's ISIN number?
Verona Pharma PLC ADR's international securities identification number is: US9250501064
What is Verona Pharma PLC ADR's CUSIP number?
Verona Pharma PLC ADR's Committee on Uniform Securities Identification Procedures number is: 925050106

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site